{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:07:22Z","timestamp":1784862442897,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T00:00:00Z","timestamp":1652486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T00:00:00Z","timestamp":1652486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Fakult\u00e4t Heidelberg der Universit\u00e4t Heidelberg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Hypercoagulability is associated with an increased risk of microvascular complications and free flap failures. The authors present their experience and approach to diagnosing and treating patients with heterozygotic factor V Leiden (hFVL) thrombophilia undergoing free flap reconstruction.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Between November 2009 and June 2018, 23 free flap surgeries were performed in 15 hypercoagulable patients with hFVL. According to the timing of perioperative hypercoagulability work-up, they were grouped into flaps with established diagnoses prior to surgery (Group A) versus flaps with unknown diagnoses prior to surgery (Group B). Baseline characteristics and perioperative complications were compared between both groups, including revision surgeries due to microvascular thromboses, acute bleedings, hematomas, flap necroses, and reconstructive failures.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>HFVL mutations had been confirmed preoperatively in 14 free flap surgeries (61%, Group A), whereas in 9 free flap surgeries (39%, Group B), mutations were only diagnosed postoperatively after the occurrence of microvascular thromboses had warranted extended hypercoagulability work-up. The overall rate of intraoperative flap thromboses was 9% (n\u2009=\u20092), whereas the overall rate of postoperative flap thromboses was 43% (n\u2009=\u200910). The corresponding salvage rates were 100% (n\u2009=\u20092\/2) for intraoperative and 40% (n\u2009=\u20094\/10) for postoperative pedicle thromboses. A total of five free flaps were lost (22%). Upon comparison, flaps with an unconfirmed diagnosis prior to surgery were at ten times higher risk for developing total necroses (flaps lost in Group B\u2009=\u20094\/9 versus Group A\u2009=\u20091\/14; OR: 10.4; 95% CI 1.0, 134.7; p\u2009=\u20090.03).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Meticulous preoperative work-up of patients with any history of hypercoagulability can help reduce free flap loss rates, thus improving surgical outcomes and increasing patient safety.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12893-022-01639-3","type":"journal-article","created":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T14:11:17Z","timestamp":1652537477000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The prognostic role of extended preoperative hypercoagulability work-up in high-risk microsurgical free flaps: a single-center retrospective case series of patients with heterozygotic factor V Leiden thrombophilia"],"prefix":"10.1186","volume":"22","author":[{"given":"Florian","family":"Falkner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Aman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Maria","family":"Risse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Wittenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Gazyakan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Harhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir K.","family":"Bigdeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Kneser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian A.","family":"Radu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,14]]},"reference":[{"issue":"7","key":"1639_CR1","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1097\/01.prs.0000260598.24376.e1","volume":"119","author":"DT Bui","year":"2007","unstructured":"Bui DT, Cordeiro PG, Hu QY, Disa JJ, Pusic A, Mehrara BJ. Free flap reexploration: indications, treatment, and outcomes in 1193 free flaps. Plast Reconstr Surg. 2007;119(7):2092\u2013100.","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"1639_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/hed.20927","volume":"31","author":"P Yu","year":"2009","unstructured":"Yu P, Chang DW, Miller MJ, Reece G, Robb GL. Analysis of 49 cases of flap compromise in 1310 free flaps for head and neck reconstruction. Head Neck. 2009;31(1):45\u201351.","journal-title":"Head Neck"},{"key":"1639_CR3","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/PRS.0b013e31823aec4d","volume":"129","author":"TY Wang","year":"2012","unstructured":"Wang TY, Serletti JM, Cuker A, McGrath J, Low DW, Kovach SJ, et al. Free tissue transfer in the hypercoagulable patient: a review of 58 flaps. Plast Reconstruct Surg. 2012;129:443\u201353.","journal-title":"Plast Reconstruct Surg"},{"issue":"4","key":"1639_CR4","doi-asserted-by":"publisher","first-page":"545e","DOI":"10.1097\/PRS.0000000000001591","volume":"136","author":"CJ Pannucci","year":"2015","unstructured":"Pannucci CJ, Kovach SJ, Cuker A. Microsurgery and the hypercoagulable state: a hematologist\u2019s perspective. Plast Reconstr Surg. 2015;136(4):545e\u201352e.","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"1639_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4236\/mps.2013.33018","volume":"3","author":"SP Davison","year":"2013","unstructured":"Davison SP, Clemens MW, Kochuba AL. Anatomy of free flap failures: dissection of a series. Mod Plast Surg. 2013;3(3):89\u201395.","journal-title":"Mod Plast Surg"},{"issue":"2","key":"1639_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.34239\/ajops.v2n2.136","volume":"2","author":"I Yeap","year":"2019","unstructured":"Yeap I, Ahn C, Hoffman S, Gillies R, Vandervord J. Current evidence for outcomes of free-flap reconstruction in factor V Leiden patients. Australas J Plast Surg. 2019;2(2):58\u201366.","journal-title":"Australas J Plast Surg"},{"key":"1639_CR7","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/S0140-6736(95)91803-5","volume":"346","author":"DC Rees","year":"1995","unstructured":"Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet. 1995;346:1133\u20134.","journal-title":"Lancet"},{"issue":"3","key":"1639_CR8","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1538-7836.2009.03711.x","volume":"8","author":"E Castoldi","year":"2009","unstructured":"Castoldi E, Rosing J. APC resistance: biological basis and acquired influences. J Thromb Haemost. 2009;8(3):445\u201353.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"1639_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000217094","volume":"24","author":"B Dahlb\u00e4ck","year":"1994","unstructured":"Dahlb\u00e4ck B. Inherited resistance to activated protein C, a major cause of venous thrombosis is due to a mutation in factor V gene. Pathophysiol Haemost Thromb. 1994;24(2):129\u201351.","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"6475","key":"1639_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/369064a0","volume":"369","author":"RM Bertina","year":"1994","unstructured":"Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, De Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369(6475):64\u20137.","journal-title":"Nature"},{"key":"1639_CR11","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1172\/JCI117623","volume":"94","author":"B Z\u00f6ller","year":"1994","unstructured":"Z\u00f6ller B, Svensson PJ, He X, Dahlb\u00e4ck B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest. 1994;94:2521\u20134.","journal-title":"J Clin Invest"},{"issue":"1","key":"1639_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/ajh.24222","volume":"91","author":"EM Van Cott","year":"2016","unstructured":"Van Cott EM, Khor B, Zehnder JL. Factor V Leiden. Am J Hematol. 2016;91(1):46\u20139.","journal-title":"Am J Hematol"},{"issue":"4","key":"1639_CR13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/micr.22199","volume":"34","author":"J Kolbenschlag","year":"2014","unstructured":"Kolbenschlag J, Daigeler A, Lauer S, Wittenberg G, Fischer S, Kapalschinski N, et al. Can rotational thromboelastometry predict thrombotic complications in reconstructive microsurgery? Microsurgery. 2014;34(4):253\u201360.","journal-title":"Microsurgery"},{"key":"1639_CR14","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(98)10266-0","volume":"353","author":"FR Rosendaal","year":"1999","unstructured":"Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet. 1999;353:1167\u201373.","journal-title":"Lancet"},{"issue":"11","key":"1639_CR15","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3949\/ccjm.67.11.825","volume":"67","author":"SR Deitcher","year":"2000","unstructured":"Deitcher SR, Caiola E, Jaffer A. Demystifying two common genetic predispositions to venous thrombosis. Cleve Clin J Med. 2000;67(11):825\u201336.","journal-title":"Cleve Clin J Med"},{"issue":"7","key":"1639_CR16","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1097\/00006534-199806000-00011","volume":"101","author":"B Arnljots","year":"1998","unstructured":"Arnljots B, S\u00f6derstr\u00f6m T, Svensson H. No correlation between activated protein C resistance and free flap failures in 100 consecutive patients. Plast Reconstr Surg. 1998;101(7):1850\u20133.","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"1639_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/micr.20879","volume":"31","author":"I Khansa","year":"2011","unstructured":"Khansa I, Colakoglu S, Tomich DC, Nguyen M, Lee BT. Factor V Leiden associated with flap loss in microsurgical breast reconstruction. Microsurgery. 2011;31(5):409\u201312.","journal-title":"Microsurgery"},{"issue":"5","key":"1639_CR18","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1097\/PRS.0b013e3181d51344","volume":"125","author":"T Friedman","year":"2010","unstructured":"Friedman T, Coon DOB, Joseph Michaels V, Bontempo F, Young VL, Clavijo JA, et al. Hereditary coagulopathies: practical diagnosis. Plast Reconstr Surg. 2010;125(5):1544\u201352.","journal-title":"Plast Reconstr Surg"},{"issue":"8","key":"1639_CR19","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1055\/s-0032-1315771","volume":"28","author":"B Sezgin","year":"2012","unstructured":"Sezgin B, Ayhan S, Tuncer S, Sencan A, Aral M. Hypercoagulability in microvascular breast reconstruction: an algorithmic approach for an underestimated situation. J Reconstr Microsurg. 2012;28(8):515\u20139.","journal-title":"J Reconstr Microsurg"},{"issue":"8","key":"1639_CR20","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/micr.22250","volume":"34","author":"H Masoomi","year":"2014","unstructured":"Masoomi H, Clark EK, Paydar KZ, Evans GRD, Nguyen A, Kobayashi MR, et al. Predictive risk factors of free flap thrombosis in breast reconstruction surgery. Microsurgery. 2014;34(8):589\u201394.","journal-title":"Microsurgery"},{"issue":"6","key":"1639_CR21","first-page":"356","volume":"70","author":"J Stepanovs","year":"2016","unstructured":"Stepanovs J, Ozolina A, Rovite V, Mamaja B, Vanags I. Factors affecting the risk of free flap failure in microvascular surgery. Proc Latv Acad Sci Sect B Nat Exact, Appl Sci. 2016;70(6):356\u201364.","journal-title":"Proc Latv Acad Sci Sect B Nat Exact, Appl Sci"},{"key":"1639_CR22","first-page":"252","volume":"90","author":"H Riess","year":"2003","unstructured":"Riess H, Koppenhagen K, Tolle A, Kemkes-matthes B, Gr\u00e4ve M, Patek F, et al. Fixed-dose, body weight-independent subcutaneous low molecular weight heparin Certoparin compared with adjusted-dose intravenous unfractionated heparin in patients with proximal deep venous thrombosis. Blood Coagul Fibrinolysis. 2003;90:252\u20139.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"4","key":"1639_CR23","first-page":"179","volume":"2","author":"JW Blom","year":"2005","unstructured":"Blom JW. Risk of venous thrombosis among cancer patients. Nat Clin Pract Oncol. 2005;2(4):179.","journal-title":"Nat Clin Pract Oncol"},{"issue":"17","key":"1639_CR24","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1056\/NEJMe2004220","volume":"382","author":"AYY Lee","year":"2020","unstructured":"Lee AYY. Anticoagulant therapy for venous thromboembolism in cancer. N Engl J Med. 2020;382(17):1650\u20132.","journal-title":"N Engl J Med"},{"issue":"17","key":"1639_CR25","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1056\/NEJMoa1915103","volume":"382","author":"G Agnelli","year":"2020","unstructured":"Agnelli G, Becattini C, Meyer G, Mu\u00f1oz A, Huisman MV, Connors JM, et al. Apixaban for the treatment of venous thromboembolism associated with cancer. N Engl J Med. 2020;382(17):1599\u2013607.","journal-title":"N Engl J Med"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-022-01639-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12893-022-01639-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-022-01639-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T14:12:32Z","timestamp":1652537552000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsurg.biomedcentral.com\/articles\/10.1186\/s12893-022-01639-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,14]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1639"],"URL":"https:\/\/doi.org\/10.1186\/s12893-022-01639-3","relation":{},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,14]]},"assertion":[{"value":"1 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the responsible ethics committee of the Rhineland-Palatinate Chamber of Physicians (Mainz, Germany) under the IRB approval reference number: 2021-15883. The need for consent is deemed unnecessary according to German national regulations (ethics committee of Rhineland-Palatinate, Germany). The study has been performed in accordance with the guidelines and regulations of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"190"}}